132 related articles for article (PubMed ID: 15335019)
1. [The use of nutritional antioxidants for the correction of metabolic disorders of cardiovascular patients].
Peresadina VR; Dmitrievskaia MN; Mal'tsev GIu; Pogozheva AV; Vasil'ev AV
Vopr Pitan; 2004; 73(3):3-6. PubMed ID: 15335019
[TBL] [Abstract][Full Text] [Related]
2. [The experience of using selenium-containing biologically active food supplements by patients during rehabilitation period after myocardial infarction].
Kravchenko IuV; Gordiushina IV; Karagizova LK; Shatokhina EV
Vopr Pitan; 2004; 73(2):11-4. PubMed ID: 15154364
[TBL] [Abstract][Full Text] [Related]
3. [The use of antioxidants for the correction of coronary risk factors in patients with myocardial ischemia].
Derbeneva SA; Pogozheva AV; Vasil'ev AV; Akol'zina SE; Lysikova SL
Vopr Pitan; 2003; 72(4):17-20. PubMed ID: 12968298
[TBL] [Abstract][Full Text] [Related]
4. [The study of soy isoflavone metabolism in patients with cardiovascular diseases].
Tutel'ian VA; Pavliuchkova MS; Pogozheva AV; Vorob'eva LSh; Derbeneva SA
Vopr Pitan; 2002; 71(4):20-2. PubMed ID: 12462950
[TBL] [Abstract][Full Text] [Related]
5. Effect of some medicinal plants on plasma antioxidant system and lipid levels in rats.
Choi EM; Hwang JK
Phytother Res; 2005 May; 19(5):382-6. PubMed ID: 16106392
[TBL] [Abstract][Full Text] [Related]
6. [The antioxidant probucol as a regulator of the intensity of free-radical lipid peroxidation processes in the blood of patients with coronary atherosclerosis].
Tikhaze AK; Lankin VZ; Mikhin VP; Revenko VM; Lupanov VP
Ter Arkh; 1997; 69(9):35-41. PubMed ID: 9411823
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of modern concepts concerning the role of processed soybean products in diet therapy of patients with cardiovascular diseases].
Tutel'ian VA; Pogozheva AV; Vysotskiĭ VG; Kondakova NM; Pavliuchkova MS
Vopr Pitan; 2000; 69(5):43-51. PubMed ID: 11247168
[TBL] [Abstract][Full Text] [Related]
8. Association between soy and green tea (Camellia sinensis) diminishes hypercholesterolemia and increases total plasma antioxidant potential in dyslipidemic subjects.
Bertipaglia de Santana M; Mandarino MG; Cardoso JR; Dichi I; Dichi JB; Camargo AE; Fabris BA; Rodrigues RJ; Fatel EC; Nixdorf SL; Simão AN; Cecchini R; Barbosa DS
Nutrition; 2008 Jun; 24(6):562-8. PubMed ID: 18455656
[TBL] [Abstract][Full Text] [Related]
9. [Effects of HuDan Granules on lipid metabolism and antioxidant activity of mice with hyperlipidemia].
Zheng MW; Zheng L
Zhong Yao Cai; 2008 Mar; 31(3):410-2. PubMed ID: 18619250
[TBL] [Abstract][Full Text] [Related]
10. [The influence of the bioflanoid dicvertin on the antioxidative system ceruloplasmin-transferrin and lipid peroxidation in patients suffering from stable coronary heart disease with dyslipidemia].
Belaia OL; Fomina IG; Baĭder LM; Kuropteva ZV; Tiukavkina NA
Klin Med (Mosk); 2006; 84(7):46-50. PubMed ID: 16924801
[TBL] [Abstract][Full Text] [Related]
11. Effect of alpha-tocopherol on the metabolic control and oxidative stress in female type 2 diabetics.
Ble-Castillo JL; Carmona-Díaz E; Méndez JD; Larios-Medina FJ; Medina-Santillán R; Cleva-Villanueva G; Díaz-Zagoya JC
Biomed Pharmacother; 2005 Jul; 59(6):290-5. PubMed ID: 15932790
[TBL] [Abstract][Full Text] [Related]
12. [Application of nutritional formulare in the dietotherapy in patients with cardiovascular diseases].
Pogozheva AV; Denisova NN; Derbeneva SA; Anykina NV; Kondakova NM
Vopr Pitan; 2005; 74(3):32-8. PubMed ID: 16044839
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women.
Garrido A; De la Maza MP; Hirsch S; Valladares L
Maturitas; 2006 Jun; 54(3):270-6. PubMed ID: 16414215
[TBL] [Abstract][Full Text] [Related]
14. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies.
Willcox BJ; Curb JD; Rodriguez BL
Am J Cardiol; 2008 May; 101(10A):75D-86D. PubMed ID: 18474278
[TBL] [Abstract][Full Text] [Related]
15. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.
Sacks FM; Lichtenstein A; Van Horn L; Harris W; Kris-Etherton P; Winston M;
Circulation; 2006 Feb; 113(7):1034-44. PubMed ID: 16418439
[TBL] [Abstract][Full Text] [Related]
16. [Lipid peroxidation and antioxidative protection in patients with coronary heart disease].
Belaia OL; Artamoshina NE; Kalmykova VI; Kuropteva ZV; Baĭder LM
Klin Med (Mosk); 2009; 87(5):21-4. PubMed ID: 19565822
[TBL] [Abstract][Full Text] [Related]
17. [Estimation of selected parameters antioxidant barrier and lipid parameters in children with atherosclerosis risk factors].
Sierakowska-Fijałek A; Fijałkowski P; Błaszczyk J; Baj Z; Stepień M; Wosik-Erenbek M; Rysz J
Pol Merkur Lekarski; 2008 Jan; 24(139):14-7. PubMed ID: 18634244
[TBL] [Abstract][Full Text] [Related]
18. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
Hadaegh F; Harati H; Ghanbarian A; Azizi F
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation.
Elango N; Samuel S; Chinnakkannu P
Clin Chim Acta; 2006 Nov; 373(1-2):92-8. PubMed ID: 16831410
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
Shehata M; Kamel MA
Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
